DXR
Daxor CorporationNASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$54.95M
P/E Ratio
5.75
EPS
$1.64
Beta
0.14
52W High
$14.76
52W Low
$7.10
50-Day MA
$11.24
200-Day MA
$11.82
Dividend Yield
—
Profit Margin
34359.00%
Forward P/E
64.52
PEG Ratio
0.00
About Daxor Corporation
Daxor Corporation, a medical device company, provides cryobank and biotechnology services in the United States. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | 26,690 |
| Gross Profit (TTM) | 26,690 |
| EBITDA | — |
| Operating Margin | -9661.00% |
| Return on Equity | 22.50% |
| Return on Assets | -1.64% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $9.07 |
| Price-to-Book | 1.20 |
| Price-to-Sales (TTM) | 2059.01 |
| EV/Revenue | 5.35 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 329.30% |
| Quarterly Revenue Growth (YoY) | -82.60% |
| Shares Outstanding | $5.83M |
| Float | $2.57M |
| % Insiders | 49.00% |
| % Institutions | 1.45% |
Historical Volatility
HV 10-Day
47.83%
HV 20-Day
38.55%
HV 30-Day
36.07%
HV 60-Day
42.29%
HV Rank
15.9%
Volatility is currently expanding
Analyst Ratings
Consensus ($22.50 target)
1
Strong Buy1
BuyData last updated: 4/14/2026